| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Krystal Biotech (NASDAQ:KRYS) has outperformed the market over the past 5 years by 19.32% on an annualized basis producing an average annual return of 32.25%. Currently, Krystal Biotech has a market capitalization of $5.13 billion.
Buying $100 In KRYS: If an investor had bought $100 of KRYS stock 5 years ago, it would be worth $446.11 today based on a price of $179.65 for KRYS at the time of writing.
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: KRYS
